Citations 2
444 Impact of homologous recombination deficiency on response to chemoimmunotherapy in biliary tract cancer
Pirozzi, Angelo, Hoyek, Celine , Okano, Naohiro, LS, Pedro, Ahn, Daniel H. , Imai-Sumida, Mitsuho, Morizane, Chigusa, Bando, Hideaki, Fujisawa, Takao , Ikeda, Masafumi, Abidoye, Oluseyi , Kosiorek, Heidi , Shibuki, Taro , Okano, Naohiro , Teixeira, Manuel , LS, Pedro, Sonbol, Mohamad Bassam , Wu, Christina N. , Yoshino, Takayuki , Morizane, Chigusa , Bando, Hideaki , Nakamura, Yoshiaki , Strickler, John H. , Borad, Mitesh J. , Ikeda, Masafumi , Bekaii‐Saab, Tanios
Regular and Young Investigator Award Abstracts | November 5, 2025 | Volume: No volume available | Issue: No issue available | Pages: A501-A501
Access Barriers to Pembrolizumab in Brazil
Rocioli, Uelson Donizeti , Sforzin, Isabella, Andriatte, Guilherme, Tustumi, Francisco , Usón, Pedro Luiz Serrano , Teixeira, Manuel , Moura, Fernando, Borad, Mitesh J. , Moreira, Flávio Tocci , Pedrotti, Carlos Henrique Sartorato
JAMA Network Open | August 22, 2025 | Volume: 8 | Issue: 8 | Pages: e2528585
10.1001/jamanetworkopen.2025.28585
This cross-sectional study examines the lawsuits that followed national and international policies for pembrolizumab approval.